A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...

The American Cancer Society (ACS) today released Cancer Statistics, 2025, the organization's annual report on cancer facts and trends. The new findings show the cancer mortality rate declined by 34% ...

Annual cancer statistics report identifies persistent racial and ethnic disparities and increases in certain cancers in women ...

Progress is lagging against pancreatic cancer, which is the third-leading cause of U.S. cancer deaths. New cases and deaths ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

A new report shows that cancer cases are increasing in females in the United States and in younger adults. For the first time ...

Cancer deaths overall are falling, but the burden is shifting toward younger adults and women, the American Cancer Society ...

Although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new ...

Though cancer mortality overall is dropping, the burden of disease is shifting to women and younger adults, American Cancer ...

Women under the age of 65 are more likely than men to be diagnosed with cancer, according to new data from the American ...

Today, the American Cancer Society (ACS) released Cancer Statistics, 2025, the organization's annual report on cancer facts ...

As KRAS-driven cancers continue to be among the most aggressive and elusive to treat, Silexion's progress with SIL-204 positions it as an important innovator to watch in the precision oncology space, ...